SCHEMBL980244

SCHEMBL980244

O=C(Cc1ccc[c]c1CCCN1CCOCC1)N1CCC(c2ccc(F)cc2)=N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.40
TSHR P16473 2/20 0.39
MET P08581 1/20 0.39
CD274 Q9NZQ7 1/20 0.38
MAPK14 Q16539 3/20 0.36
MAOB P27338 2/20 0.36
EPHX2 P34913 2/20 0.35
USP2 O75604 2/20 0.35
MAPT P10636 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
KIF11 P52732 1/20 0.35
ATM Q13315 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL979241 0.91 MET (0.40) METMAPK14EPHX2CYP3A4CYP2D6
SCHEMBL981265 0.88 KIF11 (0.45) METMAPK14EPHX2KIF11ALDH1A1
SCHEMBL982312 0.84 MAOB (0.39) METMAOBMAPTKIF11ATM
SCHEMBL980138 0.75 HCRTR1 (0.35) METMAOBKIF11KDM4EALDH1A1
SCHEMBL5050458 0.73 MET (0.46) MAOATSHRMETCD274MAPK14
SCHEMBL982788 0.72 MAOB (0.47) MAOAMAOBMAPTALDH1A1HPGD
SCHEMBL12922939 0.72 MET (0.72) METEPHX2
SCHEMBL982608 0.71 POLB (0.52) MAOAMAOBMAPTKDM4EALDH1A1
SCHEMBL980870 0.69 MAOB (0.53) MAOBUSP2MAPTALDH1A1HPGD
SCHEMBL12922889 0.69 MAOB (0.50) TSHRMAOBMAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed